How Should Pharma Feel About Reform? It Depends Who You Ask
This article was originally published in RPM Report
Executive Summary
The PhRMA annual meeting took place just days before the make or break vote on health care reform. Here is a sampling of what speakers at that event said about how industry should feel about the legislation.
You may also be interested in...
PhRMA 2014: IP, Research, and Reputation
NIH research support, intellectual property protections, and restoring the drug industry’s image moved up on the list of podium priorities at the PhRMA annual meeting in Washington, DC.
Defense-to-Offense: PhRMA Readies to Protect Government Markets
White House budget targeting biopharma with new cuts hits just as the Pharmaceutical Research & Manufacturers of America’s annual meeting gets under way.
Job One for Big Pharma: Repositioning in DC Post-Health Care Reform
How Wall Street’s reaction to the impact of health care reform may help the pharmaceutical industry make sure it pays off in the long run.